The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country.

During the past decade, MD ANDERSON CANCER CENTER (Data Collection Only) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD ANDERSON CANCER CENTER (Data Collection Only)" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Children's Hospital Los Angeles" with 1 trials as a collaborator, "M.D. Anderson Cancer Center" with 1 trials as a collaborator and "Y-mAbs Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "MD ANDERSON CANCER CENTER (Data Collection Only)" are "Endometrial Cancer" (1 trials), "Endometrial Cancer Stage I" (1 trials), "Endometrioid Adenocarcinoma" (1 trials), "Lung Cancer" (1 trials) and "Lung Metastases" (1 trials). Many other conditions were trialed in "MD ANDERSON CANCER CENTER (Data Collection Only)" in a lesser frequency.

Most popular intervention types in "MD ANDERSON CANCER CENTER (Data Collection Only)" are "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "GM-CSF" (1 trials), "Nintedanib" (1 trials), "Physical exam" (1 trials), "Placebo" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "MD ANDERSON CANCER CENTER (Data Collection Only)" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MD ANDERSON CANCER CENTER (Data Collection Only)". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MD ANDERSON CANCER CENTER (Data Collection Only), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MD ANDERSON CANCER CENTER (Data Collection Only), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".